BofA Securities raised its price target on Eli Lilly to $1,251 from $1,133 and kept a Buy rating, saying the drugmaker remains well place ...

Eli Lilly (NYSE:LLY) received another bullish call from Wall Street. Barclays analyst Emily Field raised her price target on Eli Lilly stock to $1,400 from $1,350 and reiterated an Overweight rating, ...

On Friday, Eli Lilly (LLY) saw its stock price rise more than 3% against the market trend, hitting a record high during ...

Terence Flynn, an analyst at Morgan Stanley, recently reiterated an overweight (or "buy") rating on Eli Lilly stock along with a price target of $1,327. That suggests an upside of about 52% from its ...

Eli Lilly and Company (NYSE:LLY) is included among the 10 Best US Stocks to Invest in According to Billionaires. Eli Lilly and Company (NYSE:LLY) discovers, develops, manufactures, and markets human ...